Everdime Technologies, Inc.
RGST · OTC
3/31/2024 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $25,298 | $37,340 | $37,340 | $46,512 |
| - Cash | $55 | $5 | $50 | $30 |
| + Debt | $350 | $293 | $295 | $295 |
| Enterprise Value | $25,593 | $37,627 | $37,585 | $46,776 |
| Revenue | $247 | $0 | $94 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $138 | $0 | $94 | -$12 |
| % Margin | 55.9% | – | 100% | – |
| EBITDA | $56 | -$90 | $3 | -$422 |
| % Margin | 22.7% | – | 2.9% | – |
| Net Income | $39 | -$73 | $2 | -$434 |
| % Margin | 16% | – | 2.6% | – |
| EPS Diluted | 0 | -0.001 | 0 | -0.003 |
| % Growth | 160% | -3,253.3% | 100.6% | – |
| Operating Cash Flow | $45 | -$42 | $19 | -$45 |
| Capital Expenditures | $0 | $0 | $0 | -$5 |
| Free Cash Flow | $45 | -$42 | $19 | -$50 |